SK Pharma
Agness Mikdashi has extensive experience in finance and management roles, having worked as a CFO at SK Pharma and General Manager at Life Watch. Agness has also held positions at Deloitte and PwC. Agness graduated from Tel Aviv University with a Bachelor of Arts in Accounting and Finance. Their experience includes managing professional teams, defining and monitoring policies, and preparing financial reports.
This person is not in any offices
SK Pharma
1 followers
βͺ π¦π π£πππ₯π π Group , a robust pharmaceutical company operating in over 15 countries and with close to 150 employees globally. SK-Pharma is the fastest growing generic pharma company in Israel and the Balkans with over 50 ANDA submissions a year, primarily for first to launch and complex molecules. βͺ π¦π π£πππ₯π π specializes in commercialization innovative, bio-similar and generic pharmaceuticals products in 19 countries worldwide. The geographies in focus are: Israel & PA, CIS, EMEA, LATAM, Canada, and USA, rendering high quality and lifesaving therapies available to millions. βͺ π¦π π£πππ₯π π is one stop solution for introduction of new therapeutics to answer unmet needs. Our company follows through with all demands regarding new products introduction, from registration through marketing and promotion, to distribution. βͺ π¦π π£πππ₯π π dynamic team is constantly monitoring new marketing technologies to enhance stakeholders value. We have a strong lobbying department for introduction of new pharmaceutical products, and are consistently selected as recipients of governmental tenders. Our international, multilingual, experienced staff is rigorously scouting for new technologies to improve patientsβ life, with patient centric approach philosophy, understanding the patient journey and answering heβs immediate unmet needs. βͺ Our reputation is highly important to us and we take pride in absolute, unrelenting follow-through with commitments.